Management of Therapy in a Crohn's Disease Patient With Secondary Loss of Response to Infliximab

被引：0
|
作者：
Park, Taeyang [1 ]
Skole, Kevin [2 ]
机构：
[1] Rutgers State Univ, Robert Wood Johnson Med Sch, Somerset, NJ USA
[2] Univ Med Ctr Princeton Plainsboro, Plainsboro, NJ USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S3482
引用
收藏
页码：S1805 / S1805
页数：1
相关论文
共 50 条
  • [21] Secondary Amyloidosis in a Patient with Long Duration Crohn's Disease Treated with Infliximab
    Catarina Andrade Fidalgo
    Joaquim Calado
    Marilia Cravo
    BioDrugs, 2010, 24 : 15 - 17
  • [22] Secondary Amyloidosis in a Patient with Long Duration Crohn's Disease Treated with Infliximab
    Fidalgo, Catarina
    Calado, Joaquim
    Cravo, Marilia
    BIODRUGS, 2010, 24 : 15 - 17
  • [23] Identifying Patients at High Risk of Loss of Response to Infliximab Maintenance Therapy in Paediatric Crohn's Disease
    Dupont-Lucas, Claire
    Sternszus, Robert
    Ezri, Jessica
    Leibovitch, Samantha
    Gervais, France
    Amre, Devendra
    Deslandres, Colette
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (07): : 795 - 804
  • [24] Development and validation of a clinical radiomics nomogram to predict secondary loss of response to infliximab in Crohn's disease patients
    Zhu, Chao
    Wang, Xingwei
    Wang, Shihui
    Hu, Jing
    Gao, Yankun
    Li, Cuiping
    Li, Jianying
    Wu, Xingwang
    HELIYON, 2023, 9 (04)
  • [25] Infliximab and Colchicine Therapy in the Treatment of Systemic Secondary Amyloidosis in Crohn's Disease
    You, Geoffrey
    Ferges, William
    Das, Kiron
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S443 - S443
  • [26] Babesiosis in a Patient on Infliximab for Crohn's Disease
    Cullen, Garret
    Sands, Bruce E.
    Yajnik, Vijay
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (08) : 1269 - 1270
  • [27] Efficacy of Concomitant Elemental Diet Therapy in Scheduled Infliximab Therapy in Patients with Crohn's Disease to Prevent Loss of Response
    Kamata, Noriko
    Oshitani, Nobuhide
    Watanabe, Kenji
    Watanabe, Kimihiko
    Hosomi, Shuhei
    Noguchi, Atsushi
    Yukawa, Tomomi
    Yamagami, Hirokazu
    Shiba, Matsatsugu
    Tanigawa, Tetsuya
    Watanabe, Toshio
    Tominaga, Kazunari
    Fujiwara, Yasuhiro
    Arakawa, Tetsuo
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (05) : 1382 - 1388
  • [28] Response to the Letter to the Editor: "Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease"
    Casanova, Maria Jose
    Chaparro, Maria
    Gisbert, Javier P.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (02) : E6 - E6
  • [29] Efficacy of Concomitant Elemental Diet Therapy in Scheduled Infliximab Therapy in Patients with Crohn’s Disease to Prevent Loss of Response
    Noriko Kamata
    Nobuhide Oshitani
    Kenji Watanabe
    Kimihiko Watanabe
    Shuhei Hosomi
    Atsushi Noguchi
    Tomomi Yukawa
    Hirokazu Yamagami
    Matsatsugu Shiba
    Tetsuya Tanigawa
    Toshio Watanabe
    Kazunari Tominaga
    Yasuhiro Fujiwara
    Tetsuo Arakawa
    Digestive Diseases and Sciences, 2015, 60 : 1382 - 1388
  • [30] Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
    Gisbert, Javier P.
    Panes, Julian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (03): : 760 - 767
12345